Literature DB >> 26645686

Mechanism of Folding and Activation of Subtilisin Kexin Isozyme-1 (SKI-1)/Site-1 Protease (S1P).

Joel Ramos da Palma1, Laura Cendron2, Nabil Georges Seidah3, Antonella Pasquato4, Stefan Kunz5.   

Abstract

The proprotein convertase subtilisin kexin isozyme-1 (SKI-1)/site-1 protease (S1P) is implicated in lipid homeostasis, the unfolded protein response, and lysosome biogenesis. The protease is further hijacked by highly pathogenic emerging viruses for the processing of their envelope glycoproteins. Zymogen activation of SKI-1/S1P requires removal of an N-terminal prodomain, by a multistep process, generating the mature enzyme. Here, we uncover a modular structure of the human SKI-1/S1P prodomain and define its function in folding and activation. We provide evidence that the N-terminal AB fragment of the prodomain represents an autonomous structural and functional unit that is necessary and sufficient for folding and partial activation. In contrast, the C-terminal BC fragment lacks a defined structure but is crucial for autoprocessing and full catalytic activity. Phylogenetic analysis revealed that the sequence of the AB domain is highly conserved, whereas the BC fragment shows considerable variation and seems even absent in some species. Notably, SKI-1/S1P of arthropods, like the fruit fly Drosophila melanogaster, contains a shorter prodomain comprised of full-length AB and truncated BC regions. Swapping the prodomain fragments between fly and human resulted in a fully mature and active SKI-1/S1P chimera. Our study suggests that primordial SKI-1/S1P likely contained a simpler prodomain consisting of the highly conserved AB fragment that represents an independent folding unit. The BC region appears as a later evolutionary acquisition, possibly allowing more subtle fine-tuning of the maturation process.
© 2016 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  catalysis; enzyme; prodomain; proprotein convertase; protein folding; proteolysis; transport

Mesh:

Substances:

Year:  2015        PMID: 26645686      PMCID: PMC4732194          DOI: 10.1074/jbc.M115.677757

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  37 in total

1.  The Lassa virus glycoprotein precursor GP-C is proteolytically processed by subtilase SKI-1/S1P.

Authors:  O Lenz; J ter Meulen; H D Klenk; N G Seidah; W Garten
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-16       Impact factor: 11.205

2.  Endoproteolytic processing of the lymphocytic choriomeningitis virus glycoprotein by the subtilase SKI-1/S1P.

Authors:  Winfried R Beyer; Dennis Pöpplau; Wolfgang Garten; Dorothee von Laer; Oliver Lenz
Journal:  J Virol       Date:  2003-03       Impact factor: 5.103

Review 3.  Precursor convertases in the secretory pathway, cytosol and extracellular milieu.

Authors:  Nabil G Seidah; Annik Prat
Journal:  Essays Biochem       Date:  2002       Impact factor: 8.000

4.  MAFFT: a novel method for rapid multiple sequence alignment based on fast Fourier transform.

Authors:  Kazutaka Katoh; Kazuharu Misawa; Kei-ichi Kuma; Takashi Miyata
Journal:  Nucleic Acids Res       Date:  2002-07-15       Impact factor: 16.971

5.  Crimean-Congo hemorrhagic fever virus glycoprotein proteolytic processing by subtilase SKI-1.

Authors:  Martin J Vincent; Angela J Sanchez; Bobbie R Erickson; Ajoy Basak; Michel Chretien; Nabil G Seidah; Stuart T Nichol
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

6.  UCSF Chimera--a visualization system for exploratory research and analysis.

Authors:  Eric F Pettersen; Thomas D Goddard; Conrad C Huang; Gregory S Couch; Daniel M Greenblatt; Elaine C Meng; Thomas E Ferrin
Journal:  J Comput Chem       Date:  2004-10       Impact factor: 3.376

7.  Biosynthesis and cellular trafficking of the convertase SKI-1/S1P: ectodomain shedding requires SKI-1 activity.

Authors:  Aram Elagoz; Suzanne Benjannet; Aida Mammarbassi; Louise Wickham; Nabil G Seidah
Journal:  J Biol Chem       Date:  2001-12-26       Impact factor: 5.157

8.  Mechanisms for lymphocytic choriomeningitis virus glycoprotein cleavage, transport, and incorporation into virions.

Authors:  Stefan Kunz; Kurt H Edelmann; Juan-Carlos de la Torre; Robert Gorney; Michael B A Oldstone
Journal:  Virology       Date:  2003-09-15       Impact factor: 3.616

9.  Development of protein-based inhibitors of the proprotein of convertase SKI-1/S1P: processing of SREBP-2, ATF6, and a viral glycoprotein.

Authors:  Philomena Pullikotil; Martin Vincent; Stuart T Nichol; Nabil G Seidah
Journal:  J Biol Chem       Date:  2004-02-16       Impact factor: 5.157

10.  Fine mapping of a peptide sequence containing an antigenic site conserved among arenaviruses.

Authors:  E L Weber; M J Buchmeier
Journal:  Virology       Date:  1988-05       Impact factor: 3.616

View more
  4 in total

1.  Proteolytic processing of secretory pathway kinase Fam20C by site-1 protease promotes biomineralization.

Authors:  Xinxin Chen; Jianchao Zhang; Pulan Liu; Yangyang Wei; Xi'e Wang; Junyu Xiao; Chih-Chen Wang; Lei Wang
Journal:  Proc Natl Acad Sci U S A       Date:  2021-08-10       Impact factor: 11.205

2.  A mutation in Site-1 Protease is associated with a complex phenotype that includes episodic hyperCKemia and focal myoedema.

Authors:  George G Schweitzer; Connie Gan; Robert C Bucelli; Daniel Wegner; Robert E Schmidt; Marwan Shinawi; Brian N Finck; Rita T Brookheart
Journal:  Mol Genet Genomic Med       Date:  2019-05-08       Impact factor: 2.183

3.  POST1/C12ORF49 regulates the SREBP pathway by promoting site-1 protease maturation.

Authors:  Jian Xiao; Yanni Xiong; Liu-Ting Yang; Ju-Qiong Wang; Zi-Mu Zhou; Le-Wei Dong; Xiong-Jie Shi; Xiaolu Zhao; Jie Luo; Bao-Liang Song
Journal:  Protein Cell       Date:  2020-07-14       Impact factor: 14.870

Review 4.  How Do Enveloped Viruses Exploit the Secretory Proprotein Convertases to Regulate Infectivity and Spread?

Authors:  Nabil G Seidah; Antonella Pasquato; Ursula Andréo
Journal:  Viruses       Date:  2021-06-25       Impact factor: 5.048

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.